OTC · VVCIF
VIVO Cannabis Inc.
$0.02+$0.00 (+4.79%)
VIVO Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.5% below the high.
Loading market information…
OTC · HERTF · USD
Stock price, earnings
Quote as of Aug 27, 2024, 07:45 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Heritage Cannabis Holdings Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Heritage Cannabis Holdings Corp. is a cannabinoid-focused enterprise that operates across Canada and the United States through its various subsidiaries. The company's core business involves the extraction of cannabinoids and the subsequent development of a diverse portfolio of extract-based and derivative products. These offerings are designed to serve both the adult-use recreational market and provide cannabis-based medical solutions. Heritage Cannabis provides a wide range of products under several distinct brands: Purefarma delivers medicinal-grade cannabis formulations for the pharmaceutical, recreational, and cosmeceutical sectors. Pura Vida offers concentrates derived from CBD, indica, sativa, and hybrid strains. Premium 5 specializes in tetrahydrocannabinol (THC) concentrates. The RAD brand also features various concentrates. feelgood. focuses on skincare and general wellness products. ArthroCBD provides specialized hemp-based formulations. CB4 encompasses orally administered capsules, sublingual filmstrips, and topical applications such as gels and creams. Originally incorporated in 2007 as Umbral Energy Corp., the company officially adopted its current name, Heritage Cannabis Holdings Corp., in January 2018. Its headquarters are located in Toronto, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.02+$0.00 (+4.79%)
VIVO Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.5% below the high.
A$0.02-A$0.00 (-4.76%)
Epsilon Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.12+$0.00 (+2.52%)
Acreage Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.06% below the high.
$0.00+$0.00 (+9,900.0%)
Invictus MD Strategies Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$3.25+$0.03 (+0.93%)
Guardion Health Sciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 81.94% below the high.
$0.00$0.00 (0.0%)
Oxford Cannabinoid Technologies Holdings Plc’s quoted price sits in the lower half of its reported 52-week range, 93.32% below the high.
$0.01-$0.00 (-1.95%)
Delta 9 Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.33% below the high.
$0.02$0.00 (0.0%)
Lumiera Health Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
